Verseon

Verseon is a drug discovery company founded in 2002 in the heart of Silicon Valley.

Verseon is a drug discovery company founded in 2002 in the heart of Silicon Valley. The Company’s proprietary drug discovery platform is the first systematic, computationally-driven solution to achieve the molecular modelling accuracy necessary for rapid and cost-effective drug discovery. Verseon plans to use its platform to establish a diversified discovery pipeline across multiple disease areas. Current drug programs include anticoagulation, diabetic macular edema, and oncology (solid tumors).